Pharm Dur Acquired By Acs

ACS strengthens market position with Pharm/DUR acquisition, - enhancing pharmaceutical auditing capabilities and ensuring seamless business exit for sellers

A Strategic Acquisition in the Healthcare Sector

Affiliated Computer Services Inc. (ACS), a leading business process outsourcing company, announced the acquisition of Pharm/DUR Inc.

The acquisition reinforces ACS’s presence in the pharmaceutical auditing sector, enhancing its capabilities in identifying inaccuracies in pharmacy transactions.

Expanding ACS’s Pharmaceutical Auditing Business

Dallas-based ACS (NYSE: ACS) did not disclose the financial terms of the company sale. However, the move strengthens ACS’s audit and verification business, which began five years earlier with the acquisition of Heritage Information Systems. By integrating Pharm/DUR, ACS aims to deliver enhanced auditing solutions to public and private healthcare systems.

Explore more business sales

Proprietary Technology and Market Impact

Pharm/DUR, headquartered in Philadelphia, has built a robust nationwide auditing platform designed to detect discrepancies, overpayments, and fraudulent transactions. A key asset brought into the acquisition is AUDITrack, a proprietary tool that identifies potential errors in pharmaceutical transactions.

For the 12-month period ending in April 2009, Pharm/DUR reported $6 million in revenue, highlighting its strong market presence and financial performance.

Employee Stability and Business Continuity

Christopher T. Deelsnyder, Senior Vice President and Managing Director of ACS Government Healthcare Solutions, reassured stakeholders that Pharm/DUR’s employees would remain unaffected by the business exit. This ensures continuity in service quality and operational efficiency.

Mark Sapsford led the M&A transaction advising exiting shareholders Tony Spay and  Ron Nighswander. Price and terms are undisclosed. 

More healthcare technology M&A news: UK's Quicksilva sold to Canada's Harris Corporation

Start planning your business exit today

Founder feedback

"Thank you for the transaction you completed for both Ron and me.

"Right from the start, you told us how the process would work and what we needed to prepare for each stage.  

"You were there by our sides all the way and even when you ended up in the hospital for a week we knew you were still taking calls on our transaction. You attended every meeting in each of the phases and prepared us for what the next stage would be, whilst a business sale is never easy, I don’t believe we would have completed a sale without your help and personal attention.

"We were unfortunate to not sell to the first purchaser we went into exclusivity with and you were incredibly patient with us during this phase. Your determination to progress the sale process and commitment to a positive outcome delivered a different acquirer who went on to pay a significantly higher price. 

"Ron and I were incredibly thankful for all the work you did for us in achieving the price we eventually sold the business for.

"We have been able to do all the things we had dreamed of and have felt incredibly liberated by the sale."

Anthony Spay

Co-founder & CEO, Pharm DUR Inc (USA)

“Honest and trustworthy with a great understanding of me and my business it was a pleasure to work with James and the outcome was superb. I thoroughly recommend anyone looking for corporate finance advice should speak with James.“

Ash Aggarwal

Founder, Ashchem Pharmacies

“After initial discussions with our eventual acquirer, it became clear that we needed an experienced M&A advisor to guide us through negotiations to completion.  

"Mark Sapsford at CapEQ was recommended to me, and we hit it off    straight away. Mark’s personal energy, attention to detail and problem-solving skills proved vital to smooth the path to get everything  over the line."

Polly Branney, Owner/director

Oxford ADHD & Autism Centre (UK)

We'd love to hear your story

Let's chat about your future plans. We can help you get clear on where you and your business are going.

book an informal chat with mark sapsford